| Catalog No. | HY046016 |
|---|
| Species reactivity | Human |
|---|
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| Host species | Mouse |
|---|
| Isotype | IgG1-nd |
|---|
| Expression system |
Mammalian Cells |
| Species |
Human |
| Clonality |
Monoclonal |
| Target |
Lymphocyte antigen T1/Leu-1, CD5, T-cell surface glycoprotein CD5, LEU1 |
| Endotoxin level |
Please contact with the lab for this information. |
| Purity |
>95% as determined by SDS-PAGE. |
| Purification |
Protein A/G purified from cell culture supernatant. |
| Accession |
P06127 |
| Form |
Liquid |
| Storage buffer |
0.01M PBS, pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
|
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternate Names | H65-ricin A chain immunotoxin, H65-RTA |
|---|
| Background | Zolimomab is a monoclonal antibody that specifically binds to human and cynomolgus monkey CD5. Zolimomab aritox, a variant of Zolimomab that binds to the A chain of the protein ricin, is being investigated in the treatment of systemic lupus erythematosus (SLE) and graft-versus-host disease (GVHD).
|
|---|
| Note |
For research use only. Not suitable for clinical or therapeutic use. |
